Approval Probability
TA Base Rate
Adjusted LOA
ML Risk
Testogel · 1 trial · 2 indications
| Arm | Type | Description |
|---|---|---|
| Arm 1 | ACTIVE_COMPARATOR | - |
| Arm 2 | PLACEBO_COMPARATOR | - |
| Name | Type | Description |
|---|---|---|
| Testogel (Testosterone, BAYV001915) | DRUG | 50mg (5g gel sachet), 75mg (5g+2.5g sachet) or 100mg (2x5g sachet) per day applied to the skin of the shoulders, arms or abdomen for 18 months |
| Placebo | DRUG | 5g gel sachet, 5g+2.5g sachet or 2x5g sachets per day applied to the skin of the shoulders, arms or abdomen for 6 months followed by 12 months treatment with testosterone 1% gel as described for arm 1 |
Inclusion Criteria: * Symptomatic hypogonadism * Willing to avoid significant change in the pattern of physical exercise and lifestyle for the duration of the study Exclusion Criteria: * Patients with any contraindication for testosterone use
Testogel is used for androgen deficiency in men, specifically for the treatment of partial androgen deficiency of aging males (PADAM). It is a small molecule therapy developed by Bayer AG that is currently in Phase 3 clinical development.
Testogel is a testosterone replacement therapy. It works by supplementing testosterone levels in men with androgen deficiency, addressing the hormonal imbalance associated with aging. The treatment aims to restore testosterone to normal physiological levels.
Testogel is developed by Bayer AG, a multinational pharmaceutical company. Bayer AG is publicly traded under the ticker symbol BAYRY on the OTC market.
Testogel is in Phase 3 clinical development. It has completed one Phase 3 trial, which was a randomized, double-blind, placebo-controlled study. The drug is investigational and has not yet been approved by regulatory authorities.
Testogel has one completed Phase 3 clinical trial with the identifier NCT00185198. This trial evaluated the efficacy and safety of Testogel in men with partial androgen deficiency of aging males (PADAM) and enrolled 363 participants across multiple European countries.
Testogel is a brand name for a testosterone gel formulation. It contains testosterone as the active ingredient and is designed to deliver testosterone through the skin to treat androgen deficiency in men.